Enochian Biosciences
potential application of to chronic infections including and or | Enochian Biosciences
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
37 of 43
Related slides by other companies
DiaCarta
SPAC
October 2022
infectious diseases | DiaCarta
Babylon
Investor Day
May 2022
deep dive chronic condition management | Babylon
BioNTech
Results
August 2021
disease horizon expanding the application spectrum of our technology grow mature novel technologies across oncology infectious diseases and beyond | BioNTech
Third Harmonic Bio
IPO
September 2022
third harmonic clinical stage company with oral wild type kit inhibitor to treat mast cell mediated diseases | Third Harmonic Bio
Other recent decks by Enochian Biosciences
See all presentations (3 decks)
Investor Presentation
January 2024
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights